Rachel W. Vojvodic
The University of Texas Health Science Center at Houston(US)
Publications by Year
Research Areas
Mesenchymal stem cell research, Tissue Engineering and Regenerative Medicine, Pluripotent Stem Cells Research, Mechanical Circulatory Support Devices, Cardiovascular Function and Risk Factors
Most-Cited Works
- → Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Heart Failure(2012)455 cited
- → Effect of the Use and Timing of Bone Marrow Mononuclear Cell Delivery on Left Ventricular Function After Acute Myocardial Infarction(2012)387 cited
- → A Phase II study of autologous mesenchymal stromal cells and c‐kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT‐HF trial(2021)159 cited
- → Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit + Cardiac Stem Cells As Regenerative Therapy for Heart Failure)(2018)101 cited
- → Reliability and Validity of a Questionnaire to Measure Colorectal Cancer Screening Behaviors: Does Mode of Survey Administration Matter?(2008)84 cited
- → Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction(2009)77 cited
- → Emergency Room Use and Access to Primary Care: Evidence from Houston, Texas(2006)69 cited
- LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction.(2010)
- → Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease(2017)51 cited
- → Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients(2020)48 cited